248 related articles for article (PubMed ID: 9876345)
21. Regulation of ovine fetal pituitary function by corticotrophin-releasing hormone, arginine vasopressin and cortisol in vitro.
Lü F; Yang K; Challis JR
J Endocrinol; 1994 Oct; 143(1):199-208. PubMed ID: 7964318
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
Auernhammer CJ; Melmed S
Endocrinology; 1999 Apr; 140(4):1559-66. PubMed ID: 10098488
[TBL] [Abstract][Full Text] [Related]
23. Effects of corticotrophin-releasing hormone, vasopressin and insulin-like growth factor-I on proliferation of and adrenocorticotrophic hormone secretion by canine corticotrophic adenoma cells in vitro.
van Wijk PA; Rijnberk A; Croughs RJ; Meij BP; Mol JA
Eur J Endocrinol; 1998 Mar; 138(3):309-15. PubMed ID: 9539306
[TBL] [Abstract][Full Text] [Related]
24. Hypothalamic-pituitary corticotroph function after shunting of magnocellular vasopressin and oxytocin to the hypophyseal portal circulation.
Makara GB; Kiss A; Lolait SJ; Aguilera G
Endocrinology; 1996 Feb; 137(2):580-6. PubMed ID: 8593805
[TBL] [Abstract][Full Text] [Related]
25. Corticotrophin-like intermediary lobe peptide as a marker of alternate pro-opiomelanocortin processing in ACTH-producing non-pituitary tumours.
Vieau D; Massias JF; Girard F; Luton JP; Bertagna X
Clin Endocrinol (Oxf); 1989 Dec; 31(6):691-700. PubMed ID: 2560687
[TBL] [Abstract][Full Text] [Related]
26. Effects of corticotropin-releasing hormone and dexamethasone on proopiomelanocortin messenger RNA level in human corticotroph adenoma cells in vitro.
Suda T; Tozawa F; Yamada M; Ushiyama T; Tomori N; Sumitomo T; Nakagami Y; Demura H; Shizume K
J Clin Invest; 1988 Jul; 82(1):110-4. PubMed ID: 2839542
[TBL] [Abstract][Full Text] [Related]
27. Purinergic receptor ligands stimulate pro-opiomelanocortin gene expression in AtT-20 pituitary corticotroph cells.
Zhao LF; Iwasaki Y; Oki Y; Tsugita M; Taguchi T; Nishiyama M; Takao T; Kambayashi M; Hashimoto K
J Neuroendocrinol; 2006 Apr; 18(4):273-8. PubMed ID: 16503922
[TBL] [Abstract][Full Text] [Related]
28. Effects of vasopressin and elimination of corticotropin-releasing hormone-target cells on pro-opiomelanocortin mRNA levels and adrenocorticotropin secretion in ovine anterior pituitary cells.
van de Pavert SA; Clarke IJ; Rao A; Vrana KE; Schwartz J
J Endocrinol; 1997 Jul; 154(1):139-47. PubMed ID: 9246948
[TBL] [Abstract][Full Text] [Related]
29. [Synthesis and release of CRF and ACTH in ectopic CRF/ACTH-producing tumors].
Suda T
Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):17-24. PubMed ID: 7958079
[TBL] [Abstract][Full Text] [Related]
30. RT-PCR analysis of corticotroph-associated genes expression in carcinoid tumours in the ectopic-ACTH syndrome.
Messager M; Carrière C; Bertagna X; de Keyzer Y
Eur J Endocrinol; 2006 Jan; 154(1):159-66. PubMed ID: 16382005
[TBL] [Abstract][Full Text] [Related]
31. Dysregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumours.
Tannahill LA; Visser TJ; McCabe CJ; Kachilele S; Boelaert K; Sheppard MC; Franklyn JA; Gittoes NJ
Clin Endocrinol (Oxf); 2002 Jun; 56(6):735-43. PubMed ID: 12072042
[TBL] [Abstract][Full Text] [Related]
32. Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors.
Tani Y; Sugiyama T; Izumiyama H; Yoshimoto T; Yamada S; Hirata Y
Endocr J; 2011; 58(4):297-303. PubMed ID: 21383526
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of the V3 vasopressin receptor in transgenic mice corticotropes leads to increased basal corticosterone.
René P; Grino M; Viollet C; Videau C; Jullian E; Bucchini D; Epelbaum J; Bertagna X; de Keyzer Y
J Neuroendocrinol; 2002 Sep; 14(9):737-44. PubMed ID: 12213135
[TBL] [Abstract][Full Text] [Related]
34. The release of leptin and its effect on hormone release from human pituitary adenomas.
Korbonits M; Chitnis MM; Gueorguiev M; Norman D; Rosenfelder N; Suliman M; Jones TH; Noonan K; Fabbri A; Besser GM; Burrin JM; Grossman AB
Clin Endocrinol (Oxf); 2001 Jun; 54(6):781-9. PubMed ID: 11422113
[TBL] [Abstract][Full Text] [Related]
35. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
Oyama K; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
[TBL] [Abstract][Full Text] [Related]
36. Ectopic ACTH Cushing's syndrome: V3 vasopressin receptor but not CRH receptor gene expression in a pulmonary carcinoid tumor.
Chabot V; de Keyzer Y; Gebhard S; Uské A; Bischof-Delaloye A; Rey F; Dusmet M; Gomez F
Horm Res; 1998; 50(4):226-31. PubMed ID: 9838245
[TBL] [Abstract][Full Text] [Related]
37. Mimecan in pituitary corticotroph cells may regulate ACTH secretion and the HPAA.
Ma QY; Zhang XN; Jiang H; Wang ZQ; Zhang HJ; Xue LQ; Chen MD; Song HD
Mol Cell Endocrinol; 2011 Jul; 341(1-2):71-7. PubMed ID: 21664248
[TBL] [Abstract][Full Text] [Related]
38. 125I-Tyr0-hCRH labelling characteristics of corticotropin-releasing hormone receptors: differences between normal and adenomatous corticotrophs.
Abs R; Smets G; Vauquelin G; Verhelst J; Mahler C; Verlooy J; Stevenaert A; Wouters L; Borgers M; Beckers A
Neurochem Int; 1997 Mar; 30(3):291-7. PubMed ID: 9041560
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells.
Farrell WE; Stewart MF; Clark AJ; Crosby SR; Davis JR; White A
J Mol Endocrinol; 1993 Feb; 10(1):25-32. PubMed ID: 8383976
[TBL] [Abstract][Full Text] [Related]
40. Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors.
Dahia PL; Ahmed-Shuaib A; Jacobs RA; Chew SL; Honegger J; Fahlbusch R; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1996 May; 81(5):1768-71. PubMed ID: 8626831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
